Click Title for complete article or
click Summary for overview of each
article.
Alternate
drugs not always identical [Pittsburgh
Post-Gazette]
From Pittsburgh Post-Gazette (PA)
- Jun 25,
2010
June 25--The
seizures are less frequent for Melissa Linz since
her radical brain surgery in December, when 3
inches of gray mater were removed from her
skull.
[ Summary
]
90
Days Into Health Care Reform: 64% of Retirees Say
Medicare Will Always Be There For Them, Just 23%
Confident It Will Be There for Their
Children
From
PharmaLive News Archive - Jun 23, 2010
BURLINGAME, Calif.--(BUSINESS
WIRE)--Jun 24, 2010 - A June 2010 independent
survey of 408 retirees covered by Medicare
revealed that 90 days after the passage of health
care reform legislation 64% are ?very? or
?somewhat? confident Medicare will be available
the rest of their lives, but just 23% have the
same confidence it will be here for their
children.
[ Summary
]
| FDA: New Treatments and
Technology |
| Click Title for complete article or
click Summary for overview of each
article.
FDA
OKs Abbott's new diabetes testing
strips
From
Associated Press - Jun
24, 2010
ALAMEDA,
Calif. The Food and Drug Administration approved
the products to test for levels of glucose, a type
of blood sugar, in patients with diabetes. Abbott
said the new strips contain an enzyme designed to
minimize interference with test results. North
Chicago-headquartered Abbott said it would begin
shipping test strips in August. Shares of Abbott
rose 16 cents to $47.72 in afternoon
trading.
[ Summary
]
Watson
Pharmaceuticals Inc awarded tentative FDA approval
for Fentanyl Buccal Tablets for breakthrough
cancer pain
From EquityBites - Jun 24, 2010
Speciality pharmaceutical company
Watson Pharmaceuticals Inc announced on Wednesday
that its subsidiary Watson Laboratories Inc has
received tentative approval from the US Food and
Drug Administration on its Abbreviated New Drug
Application for Fentanyl Citrate Buccal tablets,
100 mcg, 200 mcg, 300 mcg, 400 mcg, 600 mcg and
800 mcg.
[ Summary
]
FDA
warns maker of product used as alternative autism
treatment: OSR#1 is not a dietary supplement but a
toxic, unapproved drug with serious potential side
effects, FDA warns [Chicago
Tribune]
From Chicago Tribune (IL) -
Jun 24,
2010
June 24--A
product promoted to parents of children with
autism is not a harmless dietary supplement, as
claimed, but a toxic unapproved drug that lacks
adequate warnings about potential side effects,
including hair loss and abnormalities of the
pancreas, the U.S. Food and Drug Administration
has warned in a letter to its
maker.
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
Biotech
Advancements Continue to Transform Pharma
Industry
From Market Wire - Jun 28, 2010
06/28/10 -- MarketResearch.com has
announced the addition of Kalorama Information's
new report "World Pharmaceutical and
Biopharmaceutical Market, 2010-2015," to their
collection of Biopharmaceuticals market
reports.
[ Summary
]
Living,
Breathing Human Lung-On-a-Chip: A Potential
Drug-Testing Alternative
From Targeted News Service -
Jun 25,
2010
Harvard
Medical School issued the following news release:
Researchers from the Wyss Institute for
Biologically Inspired Engineering at Harvard
University, Harvard Medical School and Children's
Hospital Boston have created a device that mimics
a living, breathing human lung on a
microchip.
[ Summary
]
Abbott
enters final clinical trial of MS drug: First of
1,500 patients enroll to receive monthly injection
[Chicago Tribune]
From Chicago Tribune (IL) -
Jun 24,
2010
June
24--Abbott Laboratories and its Massachusetts
biotech partner have launched a final-stage
clinical trial of their experimental treatment for
multiple sclerosis.
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
New
route to killing cancer tried [The News and
Observer, Raleigh, N.C.]
From News & Observer
(Raleigh, NC) - Jun 24,
2010
June 24--A
targeted therapy that has generated excitement for
its early success in breast cancer is now being
tested in the Triangle on other cancers, including
often-deadly ovarian tumors. Doctors and patients
have eagerly anticipated the drugs, which provide
an entirely new route to killing tumors that is
less toxic than traditional
chemotherapies.
[
Summary
]
WVU
spinoff biotech firm tests pancreatic
drug
From
Associated Press - Jun
23, 2010
CHARLESTON, W.Va. -- A West
Virginia biotechnology company has started human
clinical trials on a new drug that would be used
to treat chronic pancreatic disease. Protea
Biosciences, West Virginia University's first
spin-off biotech firm, has teamed with French
pharmaceutical manufacturer Mayoly
Spindler.
[ Summary
]
NAMCP's Medical
Directors Resource Centers
The
purpose of NAMCP's Medical Directors Resource
Centers is to provide Medical Directors with
access to disease specific information and
resources and to improve patient
outcomes.
Accessing NAMCP's Medical
Directors Resource Centers will allow you
to:
Use screening tools to diagnose
Access treatment and best practice guidelines
Improve patient adherence and compliance
Improve patient outcomes
Better manage patients
Review cost of treatment versus overall
economic burden
Provide resources for your network physicians
Provide resources for patients
CLICK
HERE to access the Obesity Resource
Center
CLICK
HERE to access the Sleep Resource
Center
CLICK
HERE to access the Diabetes Resource
Center
CLICK THE FOLLOWING TITLES
TO PARTICIPATE IN THE ONLINE
CME/CEU
Alzheimer's
Dementia: Early Diagnosis and
Treatment
- Supported by an
educational grant from Eisai, Inc.
Improving
Patient Outcomes in Adult Asthma
-
Supported by an educational grant from
AstraZeneca
Targeted
Therapies in Non Small Cell Lung
Cancer
- Supported by an educational
grant from Boehringer Ingelheim
Pharmaceuticals
Understanding,
Diagnosing, and Managing
Fibromyalgia
- Supported by an
educational grant from Forest Laboratories and
Pfizer, Inc
What's
New In Hypertension Since The JNC 7
Guidelines
- Supported by an
educational grant from Takeda Pharmaceuticals
North America
Practical
Application of Insulin Pump Therapy In Type 2
Diabetes
- Supported by an
educational grant from Medtronic Diabetes/Lifescan
Alliance
Effective
Diagnosis and Treatment of Early Parkinson's
Disease
- Supported by an
educational grant from UCB Pharmaceuticals
Osteoporosis:
Decreasing Costs by Improving Prevention, Early
Diagnosis & Patient Outcomes
-
Supported by an educational grant from Amgen
Inc
Inattention,
Hyperactivity and Impulsivity: The Diagnosis,
Management and Treatment of Behavioral Deficits
Attributed to ADHD
- Supported by an
educational grant from Ortho-McNeil Janssen
Scientific Affairs, LLC and Shire
Pharmaceuticals
Evolution
of Personalized Medicine: The Role of
Pharmacogenomics in Managed Care
-
Supported by an educational grant from Genzyme
Corporation
Schizophrenia:
Improving Outcomes While Managing
Care
- Supported by an educational
grant from Bristol-Myers Squibb and Pfizer,
Inc.
The
Physical and Fiscal Impact of Sleep
Disorders
- Supported by an
educational grant from Cephalon and
sanofi-aventis
The
Management and Treatment of Parkinson's
Disease
- Supported by an
educational grant from Teva Neuroscience
| Journal of Managed Care
Medicine |
|
Journal of Managed Care
Medicine Vol 13, Issue 2 Table of
Contents
 Below
you will find the table of contents for the
current issue of JMCM. You can click
here to visit our main journal page, or
click on each individual article below to visit
their article page and then download the
PDF!
Click
the titles below to visit the indvidual article
download page.
Keys
to Detection of
VTE
Darrell W. Harrington,
MD, FACP
Understanding,
Diagnosing, and Managing
Fibromyalgia
Stuart
Silverman, MD, FACP FACR
Bipolar
Disorder: Developing a Cost Effective Management
Program
Jay Faber,
MD
Multiple
Myeloma: What Managed Care Needs to
Know
Laura Raftery,
MD
Targeted
Therapies in Non Small Cell Lung
Cancer
Ramaswamy Govindan,
MD
Optimizing
Patient Management: Improving Managed Care
Performance and Provider/Plan
Communication
Wendy J.
Evans, PhD, James D. Keller1, MD, and Mark I.
Evans, MD
Complete
13.2
Issue
New Data Demonstrate Efficacy and
Tolerability of Bystolic(R) (Nebivolol) Tablets
among Hispanics with
Hypertension
Forest Laboratories
presents Phase IV late-breaker results at American
Society of Hypertension Annual Meeting
NEW
YORK, May 03, 2010 (BUSINESS WIRE) -- Forest
Laboratories, Inc. (NYSE: FRX) today presented
data from a Phase IV study evaluating the effects
of Bystolic(R) (nebivolol) tablets in Hispanic
patients with hypertension at the 2010 annual
scientific meeting of the American Society of
Hypertension (ASH). Results showed Bystolic
significantly reduced sitting systolic (p=0.001)
and diastolic (p<0.0001) blood pressure (BP)
when used as monotherapy and was well tolerated.
Bystolic is a beta blocker approved by the U.S.
Food and Drug Administration for the treatment of
mild to moderate hypertension and can be used
alone or in combination with other
antihypertensive treatments.
Please click
here to view the entire release.
| Join NAMCP's LinkedIn
Group! |
|
This is a GREAT way to network with other
members, send them direct messages, post comments
or questions and learn more about your colleagues
working in other areas of managed care! If you are
a member of this professional, social network,
please search groups for NAMCP and request to join
our group for ongoing discussions, networking and
interaction with other
members!
Visit NAMCP's Career
Center!
To find a job or fill a
position, visit http://careers.namcp.org.
You can also click on the links following each
individual job below to be taken to their new page
on our career center.
Job
seekers and employers have discovered the
advantages of searching online for the best jobs
and for qualified candidates to fill them. But,
the mass-market approach of the mega job boards
may not be your best avenue.
NAMCP's Career
Center gives employers and job seeking managed
care professionals a better way to find one
another and make that perfect career
fit.
For Job Seekers: Post your
resume; Search job listings; Set up Search Agents;
and have new postings sent to you via
email.
For Employers: Post your
jobs; Target a focused audience of candidates;
Search resumes; Track applications; Promote your
company online.
If you
would like to post a job on Managed Care eNews,
please contact Sloane Reed at
sreed@namcp.org or 804-527-1905 for
rate information.
In
accordance with our mission, to enhance the
ability of our members to succeed in their
careers, we are pleased to offer comprehensive
career consultation and national executive
placement services. As a benefit of membership for
our client organizations, i.e., anyone seeking to
hire experienced staff, we offer exceptional
executive search services and at a discounted
rate. We have access to the highest caliber of
managed care talent and have a distinguished track
record in placing physician and nurse executives
as well as executive operations personnel (CEO,
COO, CFO, Director of Managed Care, Network
Development, etc.)
If you have an available
position or have an interest in our placement
service, please contact David Mara at
(804)527-1905 or e-mail at dmara@namcp.org.
For a more detailed job description for any of
the jobs listed below, please contact Dave Mara at
804.527.1905 or email him at dmara@namcp.org
You
can also CLICK HERE to visit our Job
Placement and Career Counseling page to view the
full descriptions for all of these jobs and
more!
Medical Director, Clinical Research, North
America
New Jersey
Job
Summary
The Medical Director-Clinical
Research, North America reports to the Executive
Medical Director. The incumbent is responsible for
developing and implementing product development
strategies initially in the Gastroenterology
therapeutic area but later may involve in other
therapeutic areas as derived from the company's
pipeline and/or in licensed development products.
While the individual is expected to manage the
conduct of clinical trials in the US, there is a
strong component involving participation in global
project development teams. The Medical Director
will be expected to undertake all the duties
normally associated with the execution of clinical
trials and to establish clinical advisory boards
in the areas of product development.
For
more information, please call David Mara at
804.527.1905. To review additional positions go to
www.nexushc.com
| | |
| Managed Care eNews for June 29,
2010 |
Produced by NAMCP, AAMCN, AAIHDS
4435 Waterfront Drive, Suite 101
Glen
Allen, VA 23060
Telephone:
804-527-1905
Fax:
804-747-5316
Advertising Sales:
Peter
Palmer
Professional Media Group,
Inc.
856-795-5777 ext. 13 |
Click "Opt-out of this
newsletter" at the top of the newsletter or
contact Jeremy Williams at jwilliams@namcp.org
or 804-527-1905 to be taken off the
list | | | | |
|
| NAMCP Medical Directors Resource
Centers |
|
The purpose of NAMCP's Medical Directors
Resource Centers is to provide Medical Directors
with access to disease specific information and
resources and to improve patient
outcomes.
Accessing NAMCP's Medical
Directors Resource Centers will allow you
to:
Use screening tools to diagnose
Access treatment and best practice guidelines
Improve patient adherence and compliance
Improve patient outcomes
Better manage patients
Review cost of treatment versus overall
economic burden
Provide resources for your network physicians
Provide resources for patients
CLICK
HERE to access the Obesity Resource
Center
CLICK
HERE to access the Sleep Resource
Center
CLICK
HERE to access the Diabetes Resource
Center
| | |
| NAMCP Behavioral Health Resource
Center |
|
Preventative Behavioral Health Treatment:
Depression
Early treatment and
prevention of Depression can help your heart. Find
out the latest developments on the corollary
relationship between Depression and Heart Disease,
and effective treatment methods for dealing with
these issues. For more info please click
here.
If you are interested in the
NAMCP Behavioral Health Resource Center, please
contact Katie Eads at 804-527-1905 or keads@namcp.org.
| | |
| JOURNAL OF MANAGED CARE MEDICINE
(JMCM) |
|
Vol. 13, No. 2 has been
released! Scroll below to the Journal Section
below for downloadable
articles! | | |
| UPCOMING
PROGRAMS |
|
Fall Managed Care
Forum
November 4-5,
2010
Please contact Sloane Reed at sreed@namcp.org
or Patti Hulcher at phulcher@aamcn.org
if you are interested in exhibiting or
sponsorship.
| | |
| EMPLOYMENT
OPPORTUNITIES |
|
Call Dave Mara at (804) 527-1905 for
information on any of the following job
openings.
Medical Director, Clinical Research, North
America, New Jersey
For more information or
for more detailed job descriptions, please contact
Dave Mara at 804.527.1905 or email your resume to
dmara@namcp.org
| | | |
